Yahoo Finance

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

MALVERN, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, ...
Nasdaq

Tela Bio Announces Commercial Launch Of Liquifix Devices In U.S.

(RTTNews) - Tela Bio, Inc. (TELA) announced on Thursday the launch of Liquifix FIX8 Laparoscopic and Liquifix Precision Open Hernia Mesh Fixation Devices in the U.S. These devices, produced by the U.K ...
WAVY-TV

Strong and secure, LIQUIFIX is the first approved adhesive-based product to affix mesh without penetrating patient tissue

MALVERN, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, ...
Finanznachrichten

TELA Bio, Inc.: TELA Bio Announces U.S. Commercial Launch of LIQUIFIX - the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

LIQUIFIX hernia mesh fixation devices eliminate the need for penetrating mechanical tacks, sutures, or staples by delivering a liquid adhesive that allows for precise and controlled mesh fixation. The ...